6 not yet recruiting. 6 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 6 | Not yet recruiting 6 |
Follow Urinary Bladder, Overactive: new trials by email Literature Review of Urinary Bladder, Overactive trials Research Report on Urinary Bladder, Overactive
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Defining the Safety and Efficacy of POSterIor Tibial NeRve StimulatiON in Children Urgent PC - Overactive Bladder, Overactive Bladder Syndrome | Phase 4 | Not yet recruiting | Chi Dang Hornik | 50 | 2027-04-01 | 2026-06-17 |
| Behavioral and/or Mirabegron to Treat Urinary Symptoms in Parkinson Disease mirabegron, Exercise-based behavioral therapy - Overactive Bladder, Parkinson Disease | Phase 4 | Not yet recruiting | VA Office of Research and Development | 146 | 2026-11-09 | 2026-10-27 |
| Burden and Efficacy of Anticholinergic vs Mirabegron in Overactive Bladder - A Randomized Controlled Study Solifencin, Mirabegron - Overactive Bladder (OAB) | Phase 4 | Not yet recruiting | Universidade do Porto | 208 | 2026-07-01 | 2026-07-17 |
| Pilot Deprescribing of Antimuscarinic Overactive Bladder Medications in Parkinson Disease Overactive bladder antimuscarinic deprescribing - Parkinson Disease (PD) | Phase 4 | Not yet recruiting | Corporal Michael J. Crescenz VA Medical Center | 20 | 2026-06-01 | 2026-06-04 |
| A Randomized, Placebo-controlled Trial of Nitrous Oxide During In-office Bladder Botox Injections Pro-Nox Nitrous Oxide/Oxygen Delivery System, Standard Care for Bladder Botox Injection, Sham Mask - Overactive Bladder, Neurogenic Bladder | Phase 4 | Not yet recruiting | TriHealth Inc. | 96 | 2026-02-01 | 2026-02-04 |
| Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections Lidocaine 2% without vessel constrictor - Overactive Bladder, Overactive Bladder Syndrome | Phase 4 | Not yet recruiting | University of Louisville | 36 | 2024-12-01 | 2024-11-19 |
Parkinson Disease (2) · Urinary Bladder, Neurogenic (2) · Urinary Incontinence (2) · Urinary Incontinence, Urge (2) · Agnosia (1) · Pain (1) · Pelvic Floor Disorders (1) · Urinary Bladder Diseases (1) · Urologic Diseases (1)
Female Urogenital Diseases (6) · Female Urogenital Diseases and Pregnancy Complications (6) · Lower Urinary Tract Symptoms (6) · Male Urogenital Diseases (6) · Pathological Conditions, Signs and Symptoms (6) · Signs and Symptoms (6) · Urogenital Diseases (6) · Urological Manifestations (6) · Urinary Bladder Diseases (5) · Urologic Diseases (5) · Nervous System Diseases (4) · Urination Disorders (3) · Basal Ganglia Diseases (2) · Brain Diseases (2) · Central Nervous System Diseases (2)
Lidocaine (2) · mirabegron (2) · Nitrous Oxide (1) · Oxygen (1) · Standard of Care (1) · onabotulinum toxin A (1)
Chi Dang Hornik (1) · Corporal Michael J. Crescenz VA Medical Center (1) · TriHealth Inc. (1) · Universidade do Porto (1) · University of Louisville (1) · VA Office of Research and Development (1)
United States (4)
Chi Hornik (1) · Elizabeth Camille Vaughan, MD MS (1) · Sean Francis, MD (1)
I01RD000466 (1), R33AG086944 (1)